140 Participants Needed

UHR-CT vs Conventional CT for Coronary Heart Disease

JL
Overseen ByJoao Lima, Professor
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Johns Hopkins University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether Ultra High-Resolution CT scans (UHR-CT) outperform regular CT scans in detecting blocked heart arteries in individuals with possible coronary heart disease (CHD). The researchers aim to determine if this newer scan technology can provide clearer images without requiring two separate scans. Doctors have advised potential participants to undergo a CT scan due to possible CHD. As an unphased trial, participants can help advance imaging technology that may enhance heart disease diagnosis.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.

What prior data suggests that Ultra High-Resolution Computed Tomography (UHR-CT) is safe for coronary heart disease patients?

Research has shown that Ultra High-Resolution CT (UHR-CT) scans are usually well-tolerated and very accurate in diagnosing heart artery disease. However, studies have found that UHR-CT scans expose patients to more radiation than regular CT scans. Despite this, patients handle UHR-CT similarly to regular CT scans.

Regular CT scans are commonly used and have a proven safety record. They are generally well-tolerated and involve less concern about radiation compared to UHR-CT.

Both UHR-CT and regular CT scans are non-invasive tests that help doctors take detailed pictures of the heart and blood vessels. While UHR-CT might provide clearer images, the main safety concern is the higher radiation level, so it's important to weigh the benefits and risks.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it compares two different types of CT scans to detect coronary heart disease. Unlike the standard CT scans, Ultra High-Resolution CT (UHR-CT) offers much clearer images, which can help doctors spot tiny details that might be missed otherwise. This could lead to more accurate diagnoses and better-informed treatment decisions for patients. Being able to see the heart's structure in such detail is a significant advancement, and it could mean earlier detection and intervention for coronary heart disease.

What evidence suggests that UHR-CT is effective for coronary heart disease?

This trial will compare Ultra High-Resolution CT (UHR-CT) with Conventional CT for detecting coronary heart disease (CHD). Research has shown that UHR-CT holds promise for detecting CHD. Studies indicate that UHR-CT matches the accuracy of invasive coronary angiography, a more traditional and invasive method. UHR-CT also provides clearer images of the coronary arteries, reducing errors in measuring arterial narrowing. One study found that UHR-CT could reclassify over half of patients to a lower risk category by providing more precise images. These findings suggest that UHR-CT could be a valuable tool for identifying heart disease with less invasiveness. Participants in this trial will be assigned to either the UHR-CT arm or the Conventional CT arm to evaluate these potential benefits.1678

Who Is on the Research Team?

JL

Joao Lima, Professor

Principal Investigator

MD

Are You a Good Fit for This Trial?

This trial is for individuals with various forms of heart disease, including coronary artery disease and myocardial ischemia. Participants should be generally at lower risk to assess the effectiveness of a new Ultra High-Resolution CT scan compared to conventional CT scans.

Inclusion Criteria

I am between 21 and 85 years old.
Ability to understand and willingness to sign the Informed Consent Form
My cardiologist referred me for a CTA scan due to suspected coronary heart disease.
See 1 more

Exclusion Criteria

Presence of any other history or condition that the investigator feels would be problematic
I have had multiple myeloma or an organ transplant.
My kidney function is reduced, with high creatinine or low clearance.
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Imaging

Participants undergo CT scans using either Conventional Resolution CT or Ultra-High-Resolution CT imaging modalities

1-2 weeks
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after imaging

24 months

What Are the Treatments Tested in This Trial?

Interventions

  • Conventional Computed Tomography
  • Ultra High-Resolution Computed Tomography (UHR-CT)
Trial Overview The CORE-COMPARE study is testing whether an advanced scanning technology called Ultra High-Resolution Computed Tomography (UHR-CT) can better identify blockages in the heart's arteries than standard CT scans without exposing patients to additional scans.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: UHR-CT (Ultra-High-Resolution Computed Tomography-Aquilion Precision)Experimental Treatment1 Intervention
Group II: CR-CT (Conventional Resolution Computed Tomography)Active Control1 Intervention

Conventional Computed Tomography is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:

🇪🇺
Approved in European Union as Computed Tomography for:
🇺🇸
Approved in United States as Computed Tomography for:
🇨🇦
Approved in Canada as Computed Tomography for:
🇯🇵
Approved in Japan as Computed Tomography for:
🇨🇳
Approved in China as Computed Tomography for:
🇨🇭
Approved in Switzerland as Computed Tomography for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials
2,366
Recruited
15,160,000+

Canon Medical Systems, USA

Industry Sponsor

Trials
14
Recruited
1,300+

Published Research Related to This Trial

Ultra-high resolution cerebral CT angiography (UHR-CTA) provides excellent image quality and high contrast-to-noise ratios, making it effective for visualizing small cerebral vessels and pathologies, as assessed in a study of 50 patients.
The radiation exposure from UHR-CTA is moderate, with an effective dose of 2.5 ± 0.6 mSv, indicating that it is a safe imaging option while still delivering high diagnostic value.
Feasibility of Ultra-High Resolution Supra-Aortic CT Angiography: An Assessment of Diagnostic Image Quality and Radiation Dose.Ucar, FA., Frenzel, M., Abello Mercado, MA., et al.[2022]
The ultrahigh-resolution (UHR) photon counting detector (PCD) computed tomography system demonstrated nearly equivalent spatial resolution compared to a conventional energy-integrating detector (EID) system, achieving high clarity in imaging small structures.
The PCD system produced images with 29% lower noise than the EID system, suggesting that it could allow for a 50% reduction in radiation dose while maintaining similar image quality, which is significant for patient safety.
Dose-efficient ultrahigh-resolution scan mode using a photon counting detector computed tomography system.Leng, S., Yu, Z., Halaweish, A., et al.[2020]
Coronary CT angiography (CCTA) using ultra-high-resolution computed tomography (U-HRCT) showed a remarkable sensitivity of 100% for detecting coronary artery disease (CAD) in a study of 38 patients, indicating its high efficacy as a diagnostic tool.
CCTA demonstrated excellent correlation with invasive coronary angiography (ICA) in measuring the percentage of artery stenosis, with a correlation coefficient of 0.90, although it slightly overestimated stenosis by an average of 4%, suggesting it is a reliable method for assessing coronary artery conditions.
Diagnostic performance of coronary CT angiography with ultra-high-resolution CT: Comparison with invasive coronary angiography.Takagi, H., Tanaka, R., Nagata, K., et al.[2022]

Citations

Ultra-high-resolution CT vs. Conventional Angiography for ...Diagnostic accuracy of UHR-CT using quantitative assessment of coronary artery disease is non-inferior to invasive, conventional coronary angiography for ...
Ultra-high resolution photon-counting detector coronary CT ...Photon-counting CT with ultra-high resolution improves coronary assessment. UHR-CCTA reduces overestimation bias in stenosis measurements.
Automated coronary analysis in ultrahigh-spatial resolution ...Objectives. To evaluate a deep-learning algorithm for automated coronary artery analysis on ultrahigh-resolution photon-counting detector ...
Ultrahigh-Spatial-Resolution Photon-counting Detector CT ...Ultrahigh spatial resolution of photon-counting detector CT angiography allowed for a reclassification of 54% of patients toward a lower ...
Review article CT imaging with ultra-high-resolutionIn this review we aim to describe the methods to achieve greater spatial resolution in CT that are either in clinical or preclinical stage.
Impact of ultra-high-resolution on cardiac CT assessment of ...Conclusions. Ultra-high-resolution CT image analysis results in significantly different coronary artery plaque volume and PCAT assessment vs.
Accuracy of Ultrahigh-Resolution Photon-counting CT for ...UHR photon-counting CCTA provided high diagnostic accuracy in the detection of CAD in a high-risk population, including subjects with severe coronary ...
Computed tomographic angiography in coronary artery ...This article reviews the use of coronary computed tomographic angiography in diagnosing and managing coronary artery disease, finding it can rule out ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security